BIO-RAD LABORATORIES, INC. Long Term Debt

• BIO-RAD LABORATORIES, INC. showed an increase of +0.1% in Long Term Debt from 2024 to 2025.
• This data is from BIO-RAD LABORATORIES, INC.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
• XBRL data for this metric is available from 2010 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2009: $737.92 million | Q2 2010: $734.34 million | Q3 2010: $733.57 million | Q1 2011: $731.21 million | Q2 2011: $731.33 million | Q3 2011: $731.60 million | Q1 2012: $731.90 million | Q2 2012: $732.05 million | Q3 2012: $732.23 million | Q1 2013: $732.59 million | Q2 2013: $732.80 million | Q3 2013: $435.54 million | Q4 2013: $435.62 million | Q1 2014: $435.61 million | Q2 2014: $435.61 million | Q4 2018: $438.94 million | Q1 2019: $437.61 million | Q2 2019: $437.68 million | Q3 2019: $437.81 million | Q4 2019: $13.58 million | Q1 2020: $12.21 million | Q2 2020: $12.23 million | Q3 2020: $12.24 million | Q4 2020: $12.26 million | Q1 2021: $10.90 million | Q2 2021: $10.78 million | Q3 2021: $10.65 million | Q4 2021: $10.51 million | Q1 2022: $1.20 billion | Q2 2022: $1.20 billion | Q3 2022: $1.20 billion | Q4 2022: $1.20 billion | Q1 2023: $1.20 billion | Q2 2023: $1.20 billion | Q3 2023: $1.20 billion | Q4 2023: $1.20 billion | Q1 2024: $1.20 billion | Q2 2024: $1.20 billion | Q3 2024: $1.20 billion | Q1 2025: $1.20 billion | Q2 2025: $1.20 billion | Q3 2025: $1.20 billion.
• Over the full 6 years of available data (2010 to 2025), BIO-RAD LABORATORIES, INC.'s Long Term Debt has grown by 64.4%.
• Historical annual values: Fiscal year 2025: $1.20 billion | Fiscal year 2024: $1.20 billion | Fiscal year 2013: $435.62 million | Fiscal year 2012: $732.41 million | Fiscal year 2011: $731.70 million | Fiscal year 2010: $731.10 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026